// App-Quantinova.ai

2243 : Characterization of PD-L1 expression on circulating tumor cells (CTCs) isolated with a label-free inertial microfluidic system from advanced non-small cell lung cancer patients (NSCLC pts)

Researchers

Presenter

  • Zai Ahmad

Principal Investigators

  • Jen Fraser-Fish

  • Rajiv Kumar

  • Bernadette Ebbs

  • Gemma Fowler

  • Penny Flohr

  • Mateus Crespo

  • Sanjay Popat

  • Jaishree Bhosle

  • Udai Banerji

  • Mary OBrien

  • Johann S. de Bono

  • Timothy A. Yap

Medical Centers

  • Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom

  • The Royal Marsden Hospital NHS Foundation Trust, London & Surrey, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

  • Lung Cancer

  • Solid malignancies

Biomarkers

  • Circulating tumor cells

  • Cluster of differentiation 45

  • Programmed death-ligand 1

  • Transcription termination factor 1

Drug/Treatment

  • Duet

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved